Author Interviews, Neurology, Stanford / 25.08.2022
Multiple Sclerosis: Decrease in Relapses and Brain Lesions with Ublituximab, Targeting B Cells
MedicalResearch.com Interview with:
Prof. Lawrence Steinman MD
Zimmermann Professor of Neurology & Neurological Sciences, and Pediatrics
Beckman Center for Molecular Medicine Stanford University
Stanford, CA
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: We are publishing the results of two successful phase 3 trials in relapsing MS (multiple sclerosis).
We tested a glycoengineered antibody to B cells. The glycoengineered antibody are more potent in killing the target. They can be delivered more easily. (more…)